ESC 365 - Galectin-3 and ST-2 as predictors of therapeutic success in high-risk patients undergoing percutaneous mitral valve repair (MitraClip)

ESC Premium Access

Galectin-3 and ST-2 as predictors of therapeutic success in high-risk patients undergoing percutaneous mitral valve repair (MitraClip)

Session: Poster session 2 - Mitral Valve Interventions

Topic: Mitral valve interventions

Speaker: Professor O. Doerr (Giessen, DE)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Professor Oliver Doerr

University hospital Giessen and Marburg, Giessen (Germany)

0 follower

11 more presentations in this session

MitraClip implantation as effective symptomatic therapy of dynamic mitral regurgitation unraveled by handgrip echocardiography.

Speaker: Associate Professor M. Spieker (Duesseldorf, DE)

Echocardiographic predictors for a single vs. multiclip strategy in percutaneous mitral valve repair

Speaker: Doctor B. Goebel (Bad Berka, DE)

In patients with end stage functional mitral regurgitation, mitral annulus geometry is independent on the ischemic or non-ischemic etiology of left ventricular dysfunction

Speaker: Doctor N. Ruozi (Reggio Nell'Emilia, IT)

Spherical ventricle, large left atrium size and anemia predict 1-year failure of MitraClip therapy in patients with functional mitral regurgitation

Speaker: Doctor K. Hellhammer (Duesseldorf, DE)

Impact of post-procedural mitral stenosis on long-term outcome in high-surgical risk patients treated successfully by MitraClip implantation

Speaker: Doctor D. Kalbacher (Hamburg, DE)

Access the full session

Poster session 2 - Mitral Valve Interventions

Speakers: Professor O. Doerr, Associate Professor M. Spieker, Doctor B. Goebel, Doctor N. Ruozi, Doctor K. Hellhammer...

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources